On Sept. 11, 2023, Pauline presented her reserach on Radioligand Therapy in GBM: Fibroblast Activation Protein (FAP) Promises at the 36th Annual Meeting of the European Association of Nuclear Medicine in Vienna (Autria).
Pauline presented her poster “FAP Theranostics: Opportunities and Challenges in GBM” and Fadi presented his poster “Developing Peptide-Based Theranostic Probes Targeting the Apelin Receptor in Glioblastoma” at the Annual Conference of the Society for Neuroscience 2022 in San Diego on November 14, 2022.
Fadi presented his poster “Developing Peptide-Based Theranostic Probes Targeting the Apelin Receptor in Glioblastoma” at the 2022 UCLA Biomedical Research Minor Poster Symposium on August 18, 2022.
Pauline presented her poster “Fibroblast Activation Protein (FAP) as a Target for Radioligand Therapy in Glioblastoma” at the annual meeting of the Society of Nuclear Medicine and Molecular Imaging held in Vancouver, Canada on June 10-15, 2022. She also got rewarded with a Poster Prize (3rd Place) in Basic and Translational Oncology!
We received funding from the UCLA School of Medicine and the Jonsson Comprehensive Cancer Center forTackling Glioblastoma Using Radioligand Therapy: The UCLA Neurotheranostics Program.
The Neurotheranostics program that will bring together the knowledge of GBM biology, radioligand therapy (RLT), and design of brain-penetrant ligands and pharmacology to effectively design targeted-RLT probes for the specific treatment of GBM. The program is focused on the identification of druggable targets at the surface of GBM tumors and the development of brain-penetrant molecules for PET imaging and RLT.
On Sept. 11, 2023, Pauline presented her reserach on Radioligand Therapy in GBM: Fibroblast Activation Protein (FAP) Promises at the 36th Annual Meeting of the European Association of Nuclear Medicine...
Continue reading→
Pauline presented her poster “FAP Theranostics: Opportunities and Challenges in GBM” and Fadi presented his poster “Developing Peptide-Based Theranostic Probes Targeting the Apelin Receptor in Glioblastoma” at the Annual Conference of...
Continue reading→
Fadi presented his poster “Developing Peptide-Based Theranostic Probes Targeting the Apelin Receptor in Glioblastoma” at the 2022 UCLA Biomedical Research Minor Poster Symposium on August 18, 2022.
